Skip to main content
. 2015 Dec 11;32(12):1263–1279. doi: 10.1007/s12325-015-0273-6

Table 1.

Ocular concomitant medications

Ocular concomitant therapy/indication Placebo (n = 120) Visomitin (n = 120)
Treatment period Follow-up period Treatment period Follow-up period
Lubricant/dry eye 0 6 0 2
Keratoprotector/dry eye 1 1 0 1
Antioxidants/AMD 0 0 1 1

AMD age-related macular degeneration